Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Apr 15, 2017; 9(4): 176-183
Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.176
Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.176
Variable | Total patients | Patients with VTE | Risk of time to VTE | ||
HR | 95%CI | P value | |||
Total, n (%) | 241 (100.0) | 27 (11.2) | |||
Age (yr) | |||||
< 65 | 178 (73.9) | 18 (10.1) | |||
≥ 65 | 63 (26.1) | 9 (14.3) | 1.632 | 0.732-3.641 | 0.231 |
Gender | |||||
Male | 169 (70.1) | 18 (10.7) | |||
Female | 72 (29.9) | 9 (12.5) | 1.052 | 0.472-2.345 | 0.9 |
ECOG PS | |||||
0-1 | 229 (95.0%) | 27 (11.8) | |||
2 | 12 (5.0%) | 0 | 0.046 | 0.000-99.991 | 0.432 |
BMI | |||||
< 25 | 202 (83.8) | 23 (11.4) | |||
≥ 25 | 39 (16.2) | 4 (10.3) | 0.793 | 0.274-2.296 | 0.669 |
Previous CVC | |||||
No | 233 (96.7) | 25 (10.7) | |||
Yes | 8 (3.3) | 2 (25.0) | 3.13 | 0.738-13.266 | 0.122 |
Previous gastrectomy | |||||
No | 209 (86.7) | 26 (12.4) | |||
Yes | 32 (13.3) | 1 (3.1) | 0.196 | 0.027-1.448 | 0.11 |
Primary tumor site | |||||
Antrum/pylorus | 94 (39.0) | 10 (10.6) | |||
Body | 32 (13.3) | 9 (11.0) | 1.131 | 0.458-2.791 | 0.79 |
Cardia/fundus | 28 (11.6) | 3 (10.7) | 1.138 | 0.313-4.144 | 0.844 |
Diffuse | 25 (10.4) | 5 (20.0) | 2.413 | 0.823-7.073 | 0.108 |
Histology | |||||
W/D or M/D | 84 (34.9) | 6 (7.1) | |||
P/D or SRC | 154 (63.9) | 21 (13.6) | 2.084 | 0.840-5.166 | 0.113 |
Unclassified | 3 (1.2) | 0 | NA | ||
Peritoneal seeding | |||||
No | 137 (56.8) | 11 (8.0) | |||
Yes | 104 (43.2) | 16 (15.4) | 1.945 | 0.902-4.191 | 0.09 |
Liver metastasis | |||||
No | 156 (64.7) | 20 (12.8) | |||
Yes | 85 (35.3) | 7 (8.2) | 0.741 | 0.313-1.754 | 0.495 |
Lung metastasis | |||||
No | 220 (91.3) | 26 (11.8) | |||
Yes | 21 (8.7) | 1 (4.8) | 0.509 | 0.069-3.764 | 0.509 |
Bone metastasis | |||||
No | 225 (93.4) | 24 (10.7) | |||
Yes | 16 (6.6) | 3 (18.8) | 2.344 | 0.701-7.835 | 0.167 |
Number of metastatic sites | |||||
0-1 | 109 (45.2) | 9 (8.3) | |||
≥ 2 | 132 (54.8) | 18 (13.6) | 1.898 | 0.851-1.898 | 0.118 |
CEA (log) median (range, ng/mL) | 2.5 (0.3-8070) | 1.133 | 0.947-1.355 | 0.173 | |
CA19-9 (log) median (range, U/mL) | 19.3 (1.4-30800) | 0.882 | 0.726-1.073 | 0.209 | |
CA72-4 (log) median (range, U/mL) | 5.1 (1.7-6490) | 1.099 | 0.885-1.364 | 0.395 | |
Hb median (range, g/dL) | 12.0 (7.0-17.6) | 0.956 | 0.786-1.163 | 0.653 | |
WBC median (range, × 109/L) | 7100 (2600-19300) | 1 | 1.000-1.000 | 0.026 | |
Platelet median (range, × 109/L) | 274 (107-731) | 1.001 | 0.998-1.005 | 0.508 | |
CRP median (range, mg/dL) | 2.01 (0.10-19.22) | 1.056 | 0.952-1.053 | 0.302 | |
Fibrinogen (log) median (range, × 109/L) | 360 (66-897) | 1.132 | 0.337-3.796 | 0.841 | |
PAI-1 (log) median (range, × 109/L) | 35.0 (2.0-112.0) | 1.197 | 0.662-2.165 | 0.551 | |
D-dimer (log) median (range, × 109/L) | 1.02 (0.06-82.3) | 1.401 | 1.069 1.836 | 0.015 |
- Citation: Park K, Ryoo BY, Ryu MH, Park SR, Kang MJ, Kim JH, Han S, Kang YK. Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study. World J Gastrointest Oncol 2017; 9(4): 176-183
- URL: https://www.wjgnet.com/1948-5204/full/v9/i4/176.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i4.176